Singapore markets open in 2 hours 24 minutes

Organogenesis Holdings Inc. (ORGO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.9300+0.3000 (+11.41%)
At close: 04:00PM EST
2.9300 0.00 (0.00%)
After hours: 05:35PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 340.38M
Enterprise value 363.84M
Trailing P/E 5.78
Forward P/E 11.82
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)0.74
Price/book (mrq)1.33
Enterprise value/revenue 0.78
Enterprise value/EBITDA 6.96

Trading information

Stock price history

Beta (5Y monthly) 1.50
52-week change 3-62.75%
S&P500 52-week change 3-8.00%
52-week high 39.2700
52-week low 32.2300
50-day moving average 32.6360
200-day moving average 34.1581

Share statistics

Avg vol (3-month) 3661.21k
Avg vol (10-day) 3617.01k
Shares outstanding 5130.91M
Implied shares outstanding 6N/A
Float 858.82M
% held by insiders 150.57%
% held by institutions 143.09%
Shares short (12 Jan 2023) 45.75M
Short ratio (12 Jan 2023) 47.43
Short % of float (12 Jan 2023) 416.77%
Short % of shares outstanding (12 Jan 2023) 44.39%
Shares short (prior month 14 Dec 2022) 44.92M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin 12.88%
Operating margin (ttm)9.14%

Management effectiveness

Return on assets (ttm)6.40%
Return on equity (ttm)26.82%

Income statement

Revenue (ttm)463.94M
Revenue per share (ttm)3.58
Quarterly revenue growth (yoy)2.70%
Gross profit (ttm)353.86M
Net income avi to common (ttm)59.74M
Diluted EPS (ttm)0.4800
Quarterly earnings growth (yoy)-98.30%

Balance sheet

Total cash (mrq)108.1M
Total cash per share (mrq)0.83
Total debt (mrq)130.71M
Total debt/equity (mrq)50.99
Current ratio (mrq)2.58
Book value per share (mrq)1.96

Cash flow statement

Operating cash flow (ttm)35.01M
Levered free cash flow (ttm)17.38M